Journey Medical (DERM) Gross Profit (2020 - 2026)

Journey Medical's Gross Profit history runs 7 years deep, the most recent figure standing at $9.7 million for Q1 2026.

• Quarterly Gross Profit rose 16.22% year-over-year to $9.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.7 million (up 17.17% YoY) and the FY2025 annual result came in at $40.9 million, up 19.5% from the prior year.
• Gross Profit was $9.7 million for Q1 2026 at Journey Medical, down from $10.6 million in the prior quarter.
• Across five years, Gross Profit topped out at $28.1 million in Q3 2023 and bottomed at $5.7 million in Q1 2023.
• A 5-year average of $10.6 million and a median of $9.7 million in 2026 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2023 — Gross Profit jumped 216.02% — and 2024, when it slumped 63.86%.
• Journey Medical's Gross Profit stood at $8.2 million in 2022, then jumped by 58.59% to $13.0 million in 2023, then sank by 38.97% to $7.9 million in 2024, then surged by 33.99% to $10.6 million in 2025, then fell by 8.8% to $9.7 million in 2026.
• Business Quant data shows DERM's Gross Profit at $9.7 million in Q1 2026, $10.6 million in Q4 2025, and $11.3 million in Q3 2025.